Literature DB >> 32064912

A comparative study of depressive symptomatology among cataract and age-related macular degeneration patients with impaired vision.

Ioanna Mylona1, Georgios Floros2, Maria Dermenoudi1, Nikolaos Ziakas1, Ioannis Tsinopoulos1.   

Abstract

Vision impairment remains an important cause of disability with the leading being age-related cataract (ARC) and age-related macular degeneration (ARMD) with depression symptoms often reported in vision impairment. This is a cross-sectional survey of two groups of fifty patients with ARC and ARMD and no prior psychiatric history on depressive symptomatology. Results indicate that ARMD patients scored higher on the BDI-II than ARC patients, in line with their poorer prognosis. Female patients with ARMD, living alone, with a higher number of other comorbid health issues, are more likely to have more depressive symptomatology. ARMD patients scored higher in the items related to pessimism for the future, feelings of past failure and feelings of self-dislike. There is a need for liaison psychiatry services to be readily available in patients with suspected ARC and ARMD coming forward with substantial vision loss. ARMD patients in particular tend to be more pessimistic and blame themselves for the progression of their disease. This should be taken into consideration with patient education on the causes of the disease and more effort should be undertaken to instill hope. The impact of vision loss on psychic status is related to disease prognosis and not only current state.

Entities:  

Keywords:  ARMD; Vision impairment; cataract; liaison psychiatry

Mesh:

Year:  2020        PMID: 32064912     DOI: 10.1080/13548506.2020.1728351

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  2 in total

1.  Prevalence and correlates of depressive symptoms among Chinese patients with cataracts treated in tertiary general hospitals.

Authors:  Zhong-Hua Liu; Chang-Zheng Chen; Cong Gao; De-Yi Zhou
Journal:  PeerJ       Date:  2020-06-16       Impact factor: 2.984

2.  Drop in well-being of ARMD patients under treatment with anti-VEGF injections during the COVID-19 pandemic.

Authors:  Ioanna Mylona; Kalliopi Papadopoulou; Serafeim Roumelis; Georgios D Floros
Journal:  Int Ophthalmol       Date:  2022-04-01       Impact factor: 2.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.